Innovation Health Practices

Funding Agency:
US Agency for International Development

The United States Agency for International Development (USAID) is issuing this Broad Agency Announcement (BAA) to seek participants to co-create, co-design, co-invest, and collaborate on creating, piloting, and scaling innovative research and development interventions utilizing innovative health practices to help reduce disease and mortality rates worldwide. USAID invites organizations and companies to submit an Expression of Interest (EOI) and participate in generating novel tools and approaches that accelerate and sustain improved health outcomes in low-and-middle-income countries (LMICs).

The intent of the BAA is to allow co-creation and co-design to the maximum extent to create high quality, effective partnerships with great efficiency in time and resources. USAID is seeking new applications of research & development, science, partnerships, and innovative practices in global health that provide the best value to the Government. USAID will invite selected for-profit and non-profit, public and private organizations, as detailed below, to co-create innovative research and development (R&D) solutions to the Problem and Challenge Statements stated in this BAA, including those organizations that have ideas, expertise, resources, and/or funding to add to potential solutions. In particular, this BAA welcomes co-creation from local partners based in LMICs, including the private sector, faith-based organizations, and other non-traditional USAID partners, to increase the presence and voices of local populations in solving their own health challenges.

The global community has made great strides in reducing mortality around the world over the last 50 years, but progress in developing countries lags far behind that seen in developed countries. Every year an estimated 303,000 women die during pregnancy and childbirth, 5.9 million children die, and an even greater number become infected with life threatening diseases like HIV/AIDS, malaria, diarrhea, pneumonia, and tuberculosis, among others. The vast majority of deaths due to these largely preventable causes occur in developing countries where access to health services is often poor. Outbreaks of emerging infectious diseases like Ebola and Zika only serve to further compound these health challenges, taxing already stressed health systems and elevating the risk of disease epidemics of global proportions.

CHALLENGE: Harness the power of research and development (R&D), innovation, and innovative practices in health, including science, technology, market-based approaches, and financing, to generate new knowledge, tools, and approaches that can reduce LMIC mortality down to the levels seen in high-income countries (HICs). USAID and its partners will work to identify promising R&D approaches that will help to achieve USAID’s goals of preventing child and maternal deaths, controlling the HIV/AIDS epidemic, and combating infectious diseases. The proposed concepts will be locally-oriented and aim to work in support of, and alongside, populations to find appropriate and lasting solutions to their own health challenges.

Criteria for Expressions of Interest:

1. Expressions of Interest must indicate the research or development idea which will work towards discovering potential solutions to the Problem and Challenge Statements, by increasing knowledge and understanding of potential solutions, exploiting scientific discoveries or improvements in technology, materials, processes, methods, devices, or techniques, advancing the state of the art, or using scientific and technical knowledge in the design, development, testing, or evaluation of a potential new product or service (or of an improvement in an existing product or service).

2. Potential partners will submit an Expression of Interest in response to an addendum to the USAID Global Health Broad Agency Announcement for Innovative Health Practices (2023). The release of this BAA is not an invitation for Expressions of Interest. Addenda released under this BAA will communicate specific requirements for Expressions of Interest, including but not limited to any additional details regarding the selection criteria, dates, times, and points of contact for submission

Open Period: February 21, 2023 thru February 20, 2028

Agency Website

Eligibility Requirements

Eligibility Information. Public, private, for-profit, and nonprofit organizations, as well as institutions of higher education, public international organizations, non-governmental organizations, U.S. and non-U.S. governmental organizations, multilateral and international donor organizations are eligible under this BAA. All organizations must be determined to be responsive to the BAA and sufficiently responsible to perform or participate in the final award type.

Funding Type





International Opportunities
Medical - Basic Science
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

February 20, 2028